Literature DB >> 9440599

5-HT1Dbeta receptor mediates the supersensitivity of isolated coronary artery to serotonin in variant angina.

T Ishida1, K Hirata, T Sakoda, K Kanazawa, S Kawashima, H Akita, M Yokoyama.   

Abstract

Although serotonin (5-hydroxytryptamine; 5-HT) is used for provocation of coronary spasm, 5-HT receptor subtypes in spastic coronary arteries remain undetermined. We demonstrated the supersensitivity of isolated coronary artery to ergonovine, 5-HT, and sumatriptan, a 5-HT1D receptor agonist, in a patient with variant angina. Furthermore, we detected gene expression of 5-HT1Dbeta and 5-HT2A receptors in spastic coronary artery using RNase protection assay. These findings suggest that the leftward shift of the dose-response curve for 5-HT, which plays an important role in the pathogenesis of coronary spasm, is mediated by activation of 5-HT1Dbeta receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9440599     DOI: 10.1378/chest.113.1.243

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Influence of the endothelium, nitric oxide and serotonergic receptors on coronary vasomotor responses evoked by ergonovine in conscious dogs.

Authors:  D Karila-Cohen; E Delpy; J L Dubois-Randé; L Puybasset; L Hittinger; J F Giudicelli; A Berdeaux
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

2.  Deoxyribonucleic Acid copy number aberrations in vasospastic angina patients using an array comparative genomic hybridization.

Authors:  Suk Min Seo; Yoon Seok Koh; Hae Ok Jung; Jin Soo Choi; Pum Joon Kim; Sang Hong Baek; Ho-Joong Youn; Kweon-Haeng Lee; Ki-Bae Seung
Journal:  Korean Circ J       Date:  2011-07-30       Impact factor: 3.243

Review 3.  Role of acetylcholine spasm provocation test as a pathophysiological assessment in nonobstructive coronary artery disease.

Authors:  Satoru Suzuki; Koichi Kaikita; Eiichiro Yamamoto; Hideaki Jinnouchi; Kenichi Tsujita
Journal:  Cardiovasc Interv Ther       Date:  2020-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.